Professional Documents
Culture Documents
Measles and Measles Vaccine
Measles and Measles Vaccine
Measles Vaccine
Epidemiology and Prevention of Vaccine-
Preventable Diseases
30 Pneumonia Hospitalization
25
20
Percent
15
10
0
<5 5-19 20+
Age group (yrs)
Measles Laboratory Diagnosis
• Isolation of measles virus from a
clinical specimen (e.g., nasopharynx,
urine)
• Transmission Respiratory
Airborne
900
800
Cases (thousands)
30000
25000
20000
Cases
15000
10000
5000
0
80 82 84 86 88 90 92 94 96 98 '00
*2001 provisional data
Age Distribution of Reported
Measles, 1975-2000
90 Preschool-age School-age Adult
80
70
60
Percent
50
40
30
20
10
0
1975 1980 1985 1990 1995 2000
Age group (yrs)
Measles Resurgence – United
States, 1989-1991
• Cases 55,622
• Hospitalizations >11,000
• Deaths 123
• Duration of
Immunity Lifelong
• Schedule 2 doses
• International travelers
• Health-care personnel
Measles Immunity in
Health Care Personnel
• All persons who work in
medical facilities should
be immune to measles
Measles Immunity
• Born before 1957
• Documentation of physician-
diagnosed measles
• Documentation of receipt of
measles-containing vaccine
Measles Vaccine
Indications for Revaccination
• Vaccinated before the first birthday
• Hotline 800.232.2522
• Email nipinfo@cdc.gov
• Website www.cdc.gov/nip